Point of care tool: A two-part (I, II) tool to identify individuals likely to benefit from a genomic risk assessment and those suspected to be at increased risk for hereditary breast/ovarian cancer. (Updated July 2026)
GECKO on the run: A 4-page, evidence-based summary for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing. (Updated May 2026)
GECKO deep dive: A 16-page, comprehensive evidence-based resource for healthcare providers. Features a bottom line, red flags for a genomic assessment, associated cancer risk, benefits and limitations of genetic testing, references and more. (Updated May 2026)
Related point of care tools and key links:
